Wegovy, a weight loss medication, has seen its sales skyrocket by 2,000% percent in the United Kingdom following a sudden switch by Britons from competitor Mounjaro. The switch, influenced by Mounjaro's 170% price hike, also follows a plan from the government to make weight loss products accessible to Britons as part of its 10-year health plan.
